Starting this month, Eli Lilly and Company will donate at least 200,000 KwikPens® to three relief organizations – Americares, Direct Relief and …

Health Canada has approved Invokana® (canagliflozin) as an adjunct to diet, exercise, and standard-of-care therapy, to reduce the risk of end-stage …

The U.S. Food and Drug Administration has approved Trijardy™ XR to lower blood sugar in adults with Type 2 diabetes, along with diet and …

The FDA has issued a safety alert for the weight management medicine Belviq, Belviq XR (lorcaserin) due to a possible increased risk of cancer with …

Eli Lilly today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin. The company plans to …

French drugmaker, Sanofi SA announced on Tuesday that will stop pouring in money to research diabetes and cardiovascular (DCV). The news came from …

Medically reviewed by Victor Nguyen, PharmD, MS on July 10, 2019 — Written by Helen Marshall, BPharm, MRPharmS. Republished with permission …

Medically reviewed by Dena Westphalen, PharmD on July 30, 2019 — Written by Lindsay Slowiczek, PharmD.  Republished with permission …

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s new drug, Rybelsus® (semaglutide) tablets for adults with Type 2 …

Novartis AG’s Sandoz unit, the maker of ranitidine, or Zantac, a popular heartburn medication announced today it would halt global …